TherapeuticsMD (NYSE: TXMD) announced the U.S. Patent and Trademark Office (USPTO) has approved five new allowances for patents related to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE